Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives

P Paliogiannis, AG Fois, S Sotgia… - European …, 2018 - Eur Respiratory Soc
Chronic obstructive pulmonary disease (COPD) is a disabling condition that is characterised
by poorly reversible airflow limitation and inflammation. Acute exacerbations of COPD are a …

Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives

P Paliogiannis, A Fois, S Sotgia… - European …, 2018 - researchnow.flinders.edu.au
Chronic obstructive pulmonary disease (COPD) is a disabling condition that is characterised
by poorly reversible airflow limitation and inflammation. Acute exacerbations of COPD are a …

[PDF][PDF] Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives

P Paliogiannis, AG Fois, S Sotgia, AA Mangoni… - 2018 - academia.edu
Chronic obstructive pulmonary disease (COPD) is a disabling condition that is characterised
by poorly reversible airflow limitation and inflammation. Acute exacerbations of COPD are a …

Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives

P Paliogiannis, AG Fois, S Sotgia… - … review: an official …, 2018 - pubmed.ncbi.nlm.nih.gov
Chronic obstructive pulmonary disease (COPD) is a disabling condition that is characterised
by poorly reversible airflow limitation and inflammation. Acute exacerbations of COPD are a …

[HTML][HTML] Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives

P Paliogiannis, AG Fois, S Sotgia… - European …, 2018 - Eur Respiratory Soc
Chronic obstructive pulmonary disease (COPD) is a disabling condition that is characterised
by poorly reversible airflow limitation and inflammation. Acute exacerbations of COPD are a …

[PDF][PDF] Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives

P Paliogiannis, AG Fois, S Sotgia, AA Mangoni… - 2018 - core.ac.uk
Chronic obstructive pulmonary disease (COPD) is a disabling condition that is characterised
by poorly reversible airflow limitation and inflammation. Acute exacerbations of COPD are a …

Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives.

P Paliogiannis, AG Fois, S Sotgia… - … Review: an Official …, 2018 - europepmc.org
Chronic obstructive pulmonary disease (COPD) is a disabling condition that is characterised
by poorly reversible airflow limitation and inflammation. Acute exacerbations of COPD are a …

[PDF][PDF] Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives

P Paliogiannis, AG Fois, S Sotgia, AA Mangoni… - 2018 - scholar.archive.org
Chronic obstructive pulmonary disease (COPD) is a disabling condition that is characterised
by poorly reversible airflow limitation and inflammation. Acute exacerbations of COPD are a …

[PDF][PDF] Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives

P Paliogiannis, AG Fois, S Sotgia, AA Mangoni… - 2018 - iris.uniss.it
Chronic obstructive pulmonary disease (COPD) is a disabling condition that is characterised
by poorly reversible airflow limitation and inflammation. Acute exacerbations of COPD are a …

[HTML][HTML] Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives

P Paliogiannis, AG Fois, S Sotgia… - European Respiratory …, 2018 - ncbi.nlm.nih.gov
Chronic obstructive pulmonary disease (COPD) is a disabling condition that is characterised
by poorly reversible airflow limitation and inflammation. Acute exacerbations of COPD are a …